AzurRx BioPharma Inc. (NASDAQ:AZRX) went down by -24.78% from its latest closing price compared to the recent 1-year high of $26.30. The company’s stock price has collected -34.62% of loss in the last five trading sessions. Press Release reported on 09/10/21 that AzurRx BioPharma Announces Reverse Stock Split
Is It Worth Investing in AzurRx BioPharma Inc. (NASDAQ :AZRX) Right Now?
Plus, the 36-month beta value for AZRX is at 1.50. Opinions of the stock are interesting as 3 analysts out of 4 who provided ratings for AzurRx BioPharma Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $33.33, which is -$0.77 below the current price. Today, the average trading volume of AZRX was 396.71K shares.
AZRX’s Market Performance
AZRX stocks went down by -34.62% for the week, with a monthly drop of -32.79% and a quarterly performance of -52.75%, while its annual performance rate touched -43.06%. The volatility ratio for the week stands at 16.22% while the volatility levels for the past 30 days are set at 9.75% for AzurRx BioPharma Inc.. The simple moving average for the period of the last 20 days is -32.99% for AZRX stocks with a simple moving average of -57.13% for the last 200 days.
Analysts’ Opinion of AZRX
National Securities, on the other hand, stated in their research note that they expect to see AZRX reach a price target of $9. The rating they have provided for AZRX stocks is “Buy” according to the report published on June 11th, 2019.
Oppenheimer gave a rating of “Outperform” to AZRX, setting the target price at $6 in the report published on October 17th of the previous year.
AZRX Trading at -35.87% from the 50-Day Moving Average
After a stumble in the market that brought AZRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.41% of loss for the given period.
Volatility was left at 9.75%, however, over the last 30 days, the volatility rate increased by 16.22%, as shares sank -30.54% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -49.69% lower at present.
During the last 5 trading sessions, AZRX fell by -34.62%, which changed the moving average for the period of 200-days by -47.44% in comparison to the 20-day moving average, which settled at $6.03. In addition, AzurRx BioPharma Inc. saw -57.73% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for AZRX
The total capital return value is set at -1,255.70, while invested capital returns managed to touch -3,274.23. Equity return is now at value -906.60, with -485.20 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 0.51.